Menu

Palvella Therapeutics, Inc. PVLA

Full chart Compare
Set alert

Price alert · PVLA

All alert types
174.08 USD -1.84 (-1.05%)

At closeNov 10, 2026, 5:46 AM EST

174.00 -0.08 -0.05%

Pre-market · Nov 10, 5:46 AM ET

171.88 Day range 179.32
72.23 52-week range 179.95
YTD
+66.31%
1 year
+123.67%

Revenue & Expenses

Other Income → Expenses: $10.20MExpenses → Selling, General & Admin: $16.39MExpenses → Research & Development: $52.98MGross Profit → Expenses: $25.90MRevenue → Gross Profit: $25.90MNet Loss → Expenses: $33.28MOther Income$10.20MGross Profit$25.90MNet Loss$33.28MExpenses$69.38MSelling, General & Admin$16.39MResearch & Development$52.98MRevenue$25.90M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

PVLA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
38.60M14.10M11.87M69.38M83.25M
22.84M8.15M8.79M52.98M66.66M
15.76M5.94M3.08M16.39M16.59M
-38.60M-14.10M-11.87M-43.47M-51.83M
5.82M4.32M-6.26M00
-41.72M-17.43M18.69M-33.28M-45.74M
-41.72M-17.43M17.91M-33.28M-45.74M
-41.72M-17.43M17.91M-33.28M-45.74M
-41.72M-17.43M18.69M-33.28M-45.74M
-3.71-7.832.19-36.00-57.00
-3.71-7.832.19-36.00-57.00
-3.71-7.832.17-36.00-57.00
-35.90M-13.12M12.43M-33.28M-45.74M
-35.90M-13.12M12.43M-33.28M-45.74M
11.25M2.23M1.77M927.00K807.00K
11.25M2.23M1.79M927.00K807.00K